Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Atugen enters evaluation agreement with Byk Gulden

Nov. 22, 2001

Research grant awarded for isolating potential anticancer agents from mushrooms

Nov. 22, 2001

Genzyme Molecular Oncology and Kirin Brewery form human monoclonal antibodies collaboration

Nov. 21, 2001

Japanese lab presents new Rho kinase-inhibitory amides

Nov. 20, 2001

PhotoCure reports preliminary results from phase III trial of Metvix in basal cell carcinoma

Nov. 20, 2001

Investigational cancer drug GS-7836 moves to phase I testing

Nov. 20, 2001

Supratek initiates enrollment for SP-1049C phase II trial

Nov. 20, 2001

FR-900482 analogues with antitumor activity under study in Japan

Nov. 19, 2001

Merck receives patent coverage for new GnRH antagonists

Nov. 19, 2001

New antitumor/antibacterial compounds isolated from Penicillium sp. in Japan

Nov. 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.